Emory Corporate Governance and Accountability Review
ECGAR's story begins with the financial crisis of 2008 where we were once again reminded that corporate misconduct'or at least the misconduct of those who guide corporations'has an impact reaching beyond shareholders. In the intervening years, other examples of corporate misconduct have surfaced. Federal and State False Claims Act settlements with some of the world's largest pharmaceutical manufacturers exposed facts demonstrating that through practices of misbranding and kickbacks, patients were given drugs for unapproved purposes or given drugs because of monetary inducement and not medical necessity. More recently, facts have surfaced indicating that one of the world's largest automobile manufacturers concealed material flaws in its ignition system rendering numerous cars unsafe. In light of these events, the glaring need for a publication to explore the implications of corporate misconduct became apparent.
The Origin of ECGAR,
Emory Corp. Governance & Accountability Rev.
Available at: https://scholarlycommons.law.emory.edu/ecgar/vol1/iss1/1